Can B Corp

NASDAQ:CANB USA Drug Manufacturers - Specialty & Generic
Market Cap
$2.23 Million
Market Cap Rank
#34033 Global
#11103 in USA
Share Price
$0.03
Change (1 day)
+6.91%
52-Week Range
$0.03 - $0.17
All Time High
$60.00
About

Can B Corp. develops, manufactures, and sells hemp biomass derived products containing cannabinoids. The company provides hemp cannabinoid products, including oils, creams, moisturizers, isolate, gel caps, spa products, concentrates, and lifestyle products. It sells its products under the Canbiola and Pure Leaf Oil brands through medical professionals under distribution agreements and its website… Read more

Can B Corp (CANB) - Total Assets

Latest total assets as of September 2024: $1.86 Million USD

Based on the latest financial reports, Can B Corp (CANB) holds total assets worth $1.86 Million USD as of September 2024.

Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Can B Corp - Total Assets Trend (2010–2023)

This chart illustrates how Can B Corp’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.

Can B Corp - Asset Composition Analysis

Current Asset Composition (December 2023)

Can B Corp's total assets of $1.86 Million consist of 53.1% current assets and 46.9% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 0.3%
Accounts Receivable $3.72 Million 36.8%
Inventory $1.62 Million 16.0%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $95.14K 0.9%
Goodwill $0.00 0.0%

Asset Composition Trend (2010–2023)

This chart illustrates how Can B Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Can B Corp's current assets represent 53.1% of total assets in 2023, an increase from 30.8% in 2010.
  • Cash Position: Cash and equivalents constituted 0.3% of total assets in 2023, down from 30.8% in 2010.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 17.0% in 2010.
  • Asset Diversification: The largest asset category is accounts receivable at 36.8% of total assets.

Can B Corp Competitors by Total Assets

Key competitors of Can B Corp based on total assets are shown below.

Company Country Total Assets
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
USA $67.26 Billion
Kamada
NASDAQ:KMDA
USA $378.79 Million
One World Pharma Inc
OTCQB:OWPC
USA $6.62 Million
Dongwha Pharm.Co.Ltd
KO:000020
Korea ₩654.63 Billion
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
China CN¥27.28 Billion
Yuhan Corp.
KO:000100
Korea ₩3.05 Trillion
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
China CN¥4.97 Billion
Kotra Industries Bhd
KLSE:0002
Malaysia RM363.90 Million

Can B Corp - Asset Efficiency Metrics

Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.

Asset Turnover Ratio

Measures how efficiently a company uses its assets to generate sales

Historical Range: 0.12 - 0.72

Lower asset utilization - Can B Corp generates 0.21x its asset value in annual revenue.

Return on Assets (ROA)

Measures how efficiently a company uses its assets to generate profits

Historical Range: -2695.34% - -9.82%

Negative ROA - Can B Corp is currently not profitable relative to its asset base.

Can B Corp - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 0.14 0.59 6.70
Quick Ratio 0.12 0.52 5.15
Cash Ratio 0.00 0.00 0.00
Working Capital $-10.05 Million $ -5.22 Million $ 2.88 Million

Can B Corp - Advanced Valuation Insights

This section examines the relationship between Can B Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 33.49
Latest Market Cap to Assets Ratio 0.21
Asset Growth Rate (YoY) -34.9%
Total Assets $10.13 Million
Market Capitalization $2.15 Million USD

Valuation Analysis

Below Book Valuation: The market values Can B Corp's assets below their book value (0.21 x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Can B Corp's assets decreased by 34.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Can B Corp (2010–2023)

The table below shows the annual total assets of Can B Corp from 2010 to 2023.

Year Total Assets Change
2023-12-31 $10.13 Million -34.92%
2022-12-31 $15.56 Million -5.55%
2021-12-31 $16.47 Million +189.46%
2020-12-31 $5.69 Million -17.88%
2019-12-31 $6.93 Million +87.64%
2018-12-31 $3.69 Million +1584.25%
2017-12-31 $219.31K +60.10%
2016-12-31 $136.98K -4.06%
2015-12-31 $142.78K -47.28%
2014-12-31 $270.84K +50.30%
2013-12-31 $180.20K -33.52%
2012-12-31 $271.05K -80.57%
2011-12-31 $1.39 Million +4638.04%
2010-12-31 $29.44K --